Webinar "digitalMLPA and MLPA: Copy Number Analysis Made Simple for Childhood Cancers" is Available On-Demand
May 27, 2024
Wondering how SALSA® digitalMLPA™ and SALSA® MLPA® can streamline your workflow to study CNAs in childhood cancers? Presented by the head of our oncogenetics team Suvi Savola, this on-demand webinar:
- Provides an overview of our most popular products for molecular characterisation of childhood cancers.
- Shows how digitalMLPA and MLPA allow confident copy number calling, even in the most complex genomic regions.
- Dives deep into two of our assays relevant for childhood leukemias: SALSA® digitalMLPA™ Probemix D007 Acute Lymphoblastic Leukemia and SALSA® MLPA® Probemix P496 KMT2A.